NYU Langone Neurosurgery Update: A One Day Symposium

  06 Dec 2024 - 06 Dec 2024

   New York, NY, United States

conference-img

NYU Langone Neurosurgery Update: A One Day Symposium

06 Dec 2024

 - 

06 Dec 2024

New York, NY, United States



The spectrum of neurosurgery includes cranial, spinal, and peripheral nerve disorders related to vascular disease, brain tumors, pain, movement and behavioral disorders, epilepsy, and trauma. Clinical challenges in both adults and children are managed by neurosurgeons together with partners in neurology, oncology, radiation oncology, otolaryngology, radiology, pathology, rehabilitation medicine, and neuroscience.

This one day-program will address significant clinical problems for which there may be clinical equipoise on available options, or for which current science does not provide solutions based on high-level medical evidence.

International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


International Conference on Sexual and Reproductive Health

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


International Conference on Sexual and Reproductive Health

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

2.

FDA approves Blenrep for relapsed or refractory multiple myeloma

3.

X-ray and radar technology combined to reduce cancer screening risks

4.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

5.

Researchers discuss HER2-low and HER2-zero in breast cancer

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot